Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (4262)	5/7/1998 12:45:00 PM
From: Bhag Karamchandani	Read Replies (2) of 6136

RE: Shorts : you can see from recent trading that shorts try and cover based on good news. But it takes more than prospective good news to deter them, specially when there is so much dis information: cures for AIDS ( scientific perspective, probably, many many years away); hyped cancer therapies being touted (where mice get equated to men - by leap of journalistic faith and despite researcher disclaimers). Positive factors which would deter shorts- pending Phase II/III AG3340 results :increase in position by institutional investors; purchases by insiders ( this is probably the one of the most negative indicators hurting AGPH price); buyout offer for AGPH ( even if it is rejected) Interestingly, Johnson ( CNBC interview) did not say anything about AGPH acquiring players smaller than itself , or categorically rule out AGPH being acquired. Should one read anything into this?? I don't know. Q: Does any one know anything about AGPH's work on second generation MMP inhibitors,Johnson alluded to on CNBC. I did not find anything on the AGPH web site.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next